Aegis Capital is sole bookrunner, with Feltl assisting in stock sale
By Toni Weeks
San Luis Obispo, Calif., April 5 - Underwriters for Cancer Genetics, Inc.'s $6 million initial public offering of stock fully exercised their over-allotment option, lifting total proceeds to $6.9 million.
The company priced 600,000 shares at $10.00 apiece with a 90,000-share greenshoe on April 4. It expects the shares to trade on the OTCBB under the symbol "CGIX."
Aegis Capital Corp. is the sole bookrunning manager.
Settlement is expected April 10.
The Rutherford, N.J., diagnostics company is focused on developing genomic-based, oncology tests and services.
| Issuer: | Cancer Genetics, Inc.
|
| Issue: | Common stock
|
| Amount: | $6.9 million (including $900,000 greenshoe)
|
| Shares: | 690,000
|
| Price: | $10.00
|
| Warrants: | No
|
| Bookrunner: | Aegis Capital Corp.
|
| Co-manager: | Feltl and Co., Inc.
|
| Pricing date: | April 4
|
| Upsized: | April 5
|
| Settlement date: | April 10
|
| Stock exchange: | OTCBB: CGIX
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
